RELIAB Trademark

Trademark Overview

On Monday, June 9, 2008, a trademark application was filed for RELIAB with the United States Patent and Trademark Office. The USPTO has given the RELIAB trademark a serial number of 77494009. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 14, 2012. This trademark is owned by Glaxo Group Limited. The RELIAB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
reliab

General Information

Serial Number77494009
Word MarkRELIAB
Filing DateMonday, June 9, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 14, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 20, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 12, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Monday, May 14, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 14, 2012ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 8, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 7, 2011EXTENSION 5 GRANTED
Tuesday, October 4, 2011EXTENSION 5 FILED
Tuesday, October 4, 2011TEAS EXTENSION RECEIVED
Tuesday, March 22, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2011EXTENSION 4 GRANTED
Tuesday, March 15, 2011EXTENSION 4 FILED
Tuesday, March 15, 2011TEAS EXTENSION RECEIVED
Tuesday, September 21, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 19, 2010EXTENSION 3 GRANTED
Tuesday, September 14, 2010EXTENSION 3 FILED
Tuesday, September 14, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 13, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 12, 2010EXTENSION 2 GRANTED
Tuesday, March 16, 2010EXTENSION 2 FILED
Monday, April 12, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 16, 2010TEAS EXTENSION RECEIVED
Thursday, February 25, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 25, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 21, 2009EXTENSION 1 GRANTED
Monday, September 21, 2009EXTENSION 1 FILED
Monday, September 21, 2009TEAS EXTENSION RECEIVED
Tuesday, September 8, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 8, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 14, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 20, 2009PUBLISHED FOR OPPOSITION
Wednesday, December 31, 2008NOTICE OF PUBLICATION
Monday, December 15, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 10, 2008ASSIGNED TO LIE
Thursday, December 4, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 18, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 18, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 18, 2008TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, September 19, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, September 19, 2008LETTER OF SUSPENSION E-MAILED
Friday, September 19, 2008SUSPENSION LETTER WRITTEN
Wednesday, September 17, 2008ASSIGNED TO EXAMINER
Thursday, June 12, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

reliab pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic